Abstract: A transmission parking system is provided. The system includes a parking gear and a parking rod that is connected with the parking gear. Additionally, a parking lever has a first end that is connected with the parking rod and the parking lever is installed rotatably around a control shaft. A detent return spring is wound around an exterior circumference of the control shaft, supports the parking lever, and provides elastic force to rotate the parking lever and return to an original position. A control lever is installed rotatably around the control shaft and is installed at an exterior side of the parking lever to allow user operation. A neutral state maintaining lock and release device is connected with the control lever and is changed to a neutral state lock or a neutral state release based on operation of the control lever.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention is directed toward monoclonal antibodies that bind to death receptor 4 and/or death receptor 5, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention relates to an operation method of a washing machine for controlling the rotation of a pulsator to enhance cleaning performance, there is provided a method of operating a washing machine having a pulsator rotatably provided in a tub, and the method may include a first cleaning mode having a first process of rotating the pulsator in one direction at a first angle and then rotating it in the other direction at a second angle around the rotation shaft; and a second process of rotating the pulsator in the one direction at a third angle and then rotating it in the other direction at a fourth angle around the rotation shaft, wherein the first angle is greater than the third angle, and the second angle is greater than the fourth angle, and the second angle is greater than the third angle.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: A method of controlling a vehicle washing mode for a vehicle equipped with shift-by-wire shifting device, may include performing an N-range-off determining step that determines whether a shift lever is in an N-range when an engine stops, performing an ACC determining step that determines whether the vehicle is in an ACC state, and performing a shifting step that shifts a P-range state of a transmission to a N-range state thereof by operating an actuator, when the N-range-off determining step determines that the shift lever is in the N-range when the engine was stopped, and when the ACC determining step determines that the vehicle is in the ACC state.

Abstract: A method of controlling a vehicle washing mode for a vehicle equipped with shift-by-wire shifting device, may include performing an N-range-off determining step that determines whether a shift lever is in an N-range when an engine stops, performing an ACC determining step that determines whether the vehicle is in an ACC state, and performing a shifting step that shifts a P-range state of a transmission to a N-range state thereof by operating an actuator, when the N-range-off determining step determines that the shift lever is in the N-range when the engine was stopped, and when the ACC determining step determines that the vehicle is in the ACC state.

Abstract: The present invention provides a bispecific antibody having a binding domain that binds to FGF2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The automatic transmission system includes a shift lever for changing stages by a user, a shift-lock device for fixing or releasing the shift lever, and a control unit including a shift control logic changing the stages of the transmission in accordance with the stage changed by the shift lever and a shift-lock control logic controlling the shift-lock device by stages for an initial time and a maintenance time after the initial time from when the stages may be changed such that the shift lever may be fixed, in order to shift-lock the shifted shift lever when the stages may be changed by the shift control logic.

Abstract: The present invention is directed toward a humanized neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: A control method for a parking release apparatus of a shift-by-wire shifting device can improve the commercial value of a vehicle by improving safety of the vehicle and preventing robbery, by interfering with or preventing an attempt of abnormally and manually releasing a parking state of the vehicle when there is no problem in the electric system of the vehicle, using a part provided to be manually operated in the parking release apparatus such that a P-stage state and an N-stage state can be manually switched when a problem, such as discharge, occurs in the electric system, in the vehicle equipped with a shift by wire apparatus.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: A method of controlling a vehicle washing mode for a vehicle equipped with shift-by-wire shifting device, may include performing an N-range-off determining step that determines whether a shift lever is in an N-range when an engine stops, performing an ACC determining step that determines whether the vehicle is in an ACC state, and performing a shifting step that shifts a P-range state of a transmission to a N-range state thereof by operating an actuator, when the N-range-off determining step determines that the shift lever is in the N-range when the engine was stopped, and when the ACC determining step determines that the vehicle is in the ACC state.

Abstract: A method of controlling a vehicle washing mode for a vehicle equipped with shift-by-wire shifting device, may include performing an N-range-off determining step that determines whether a shift lever is in an N-range when an engine stops, performing an ACC determining step that determines whether the vehicle is in an ACC state, and performing a shifting step that shifts a P-range state of a transmission to a N-range state thereof by operating an actuator, when the N-range-off determining step determines that the shift lever is in the N-range when the engine was stopped, and when the ACC determining step determines that the vehicle is in the ACC state.

Abstract: The present invention is directed toward a humanized neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.